Comparer des méthodes
Examinez les méthodes sélectionnées côte à côte ; les lignes qui diffèrent sont mises en évidence.
| Questionnaire sur la qualité de vie dans la rhinoconjonctivite× | Sinonasal Outcome Test-22× | |
|---|---|---|
| Domaine | Pneumologie | Pneumologie |
| Famille | Process / pipeline | Process / pipeline |
| Année d'origine≠ | 1996 | 2009 |
| Auteur d'origine≠ | Elizabeth F. Juniper, McMaster University | Claire Hopkins, King's College London |
| Type | Self-report questionnaire | Self-report questionnaire |
| Source fondatrice≠ | Juniper, E. F., Guyatt, G. H., Streiner, D. L., & King, D. R. (1996). Clinical validation and responsiveness of three scales developed to measure the effect of allergic rhinitis on quality of life. Journal of Clinical Epidemiology, 49(3), 339-347. link ↗ | Hopkins, C., Gillett, S., Slack, R., Lund, V. J., & Browne, J. P. (2009). Psychometric validity of the 22-item Sinonasal Outcome Test. Clinical Otolaryngology, 34(5), 447-454. DOI ↗ |
| Alias | RQLQ, Rhinoconjunctivitis QoL | SNOT-22, SNOT |
| Apparentées | 5 | 5 |
| Résumé≠ | The RQLQ is a 28-item disease-specific quality-of-life instrument developed by Juniper and colleagues at McMaster University in 1996 to assess the impact of allergic rhinitis and allergic conjunctivitis on daily functioning. It captures symptom burden and activity limitation across seven domains: sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, activity limitation, and emotional function. The RQLQ is the preferred outcome measure in allergic rhinitis clinical trials and is widely used in allergy and immunology practice to track treatment response. | The SNOT-22 is a 22-item disease-specific quality-of-life questionnaire designed to assess sino-nasal symptoms and their functional impact on patients with chronic rhinosinusitis, nasal polyposis, and allied conditions. Developed by Hopkins and colleagues at King's College London in 2009, it has become the most widely used instrument for measuring sino-nasal disease burden in clinical trials and rhinological practice. The SNOT-22 provides rapid, patient-centered assessment of both nasal-specific symptoms (congestion, drainage, sneezing) and general health impacts (sleep, headache, concentration). |
| ScholarGateJeu de données ↗ |
|
|